Back to search

PES2020-Prosj.etabl.støtte H2020

PES Application for Paradigme

Awarded: NOK 37,689

The goal is to submit an application to Horizon 2020 for support to the Paradigme study, which is a pivotal phase 2 clinical study for Betalutin, a novel antibody radionuclide conjugate for treatment of follicular lymphoma.

Funding scheme:

PES2020-Prosj.etabl.støtte H2020